Failing the Public Health - Rofecoxib, Merck, and the FDA

  • Topol, Eric J.

  • From the Cleveland Clinic Foundation, Cleveland.

New England Journal of Medicine 351(17):p 1707-1709, October 21, 2004. | DOI: 10.1056/NEJMp048286
Copyright © 2004 Massachusetts Medical Society. All rights reserved.
View full text|Download PDF